Sankyo signs up Singapore pharma for natural product leads
Thursday, 21 April, 2005
Private Singapore natural products company MerLion Pharmaceuticals has sealed a three-year cooperative drug discovery and development collaboration with Japan's Sankyo.
The companies will collaborate on both the lead discovery and optimisation stages of the collaboration. Sankyo will provide selected high-throughput screens and additional assays to MerLion, which will provide access to its sample collection. Sankyo will undertake clinical development and commercialisation of the discoveries.
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
